Showing results (41-50 of 77) with videos related to
Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|April 1, 1994
Transplacental pharmacokinetics of dideoxyinosine in pigtailed macaquesC M Pereira, C Nosbisch, H R Winter, et al.Clinical Pharmacology and Therapeutics|April 1, 1991
Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprimR M Hutabarat, J D Unadkat, C Sahajwalla, et al.Anesthesia and Analgesia|September 1, 1991
Age affects the pharmacokinetics of inhaled anesthetics in humansD P Strum, E I Eger, J D Unadkat, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 1995
Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugsJ R Palamanda, D Hickman, A Ward, et al.Anesthesiology|August 1, 1986
The extent of metabolism of inhaled anesthetics in humansR L Carpenter, E I Eger, B H Johnson, et al.AIDS Research and Human Retroviruses|August 1, 1995
Simian immunodeficiency virus infection of macaque primary placental cellsT Bui, R Watanabe, B Kennedy, et al.Journal of Cardiothoracic Anesthesia|February 1, 1988
Isoflurane elimination via a bubble oxygenator during extracorporeal circulationS L Price, D L Brown, R L Carpenter, et al.Anesthesia and Analgesia|June 1, 1986
Pharmacokinetics of inhaled anesthetics in humans: measurements during and after the simultaneous administration of enflurane, halothane, isoflurane, methoxyflurane, and nitrous oxideR L Carpenter, E I Eger, B H Johnson, et al.Anesthesia and Analgesia|January 1, 1987
Does the duration of anesthetic administration affect the pharmacokinetics or metabolism of inhaled anesthetics in humans?R L Carpenter, E I Eger, B H Johnson, et al.Biopharmaceutics & Drug Disposition|December 18, 2001
CYP3A inductive potential of the rifamycins, rifabutin and rifampin, in the rabbitA Weber, M Kaplan, S A Chughtai, et al.Pageof 8